Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
12 2021
Historique:
received: 30 04 2021
revised: 01 09 2021
accepted: 01 09 2021
pubmed: 7 9 2021
medline: 1 3 2022
entrez: 6 9 2021
Statut: ppublish

Résumé

Polysorbates (PS) are surfactants commonly added in biologics formulations that can protect proteins from denaturation and aggregation. However, decreases in polysorbate 20 (PS20) content have been observed in some monoclonal antibody formulations, causing the formation of visible and/or subvisible particles that ultimately compromise the quality and stability of the therapeutic protein products. It was determined that the particles are mainly composed of free fatty acid, suggesting enzymatic hydrolysis of PS is responsible for the degradation of PS. Enrichment of host cell proteins (HCPs) by immunoprecipitation followed by shotgun proteomics have been utilized to identify the HCPs that can hydrolyze PS20. One HCP, sialate O-acetylesterase (SIAE), demonstrated strong enzymatic activity for PS20 degradation even at low concentration (<5 ppm level). Incubation of recombinant SIAE with PS20 resulted in a unique degradation pattern where the hydrolysis of monoester with short fatty acid chain (C12, C14) was observed but not the monoester with long fatty acid chain (C16, C18) or higher-order esters. SIAE was detected and quantitated in several formulated mAbs, and the amount of SIAE was positively correlated to PS20 degradation in these mAbs during incubation. Additional experiments also showed that when SIAE was depleted, PS20 degradation was diminished, suggesting a causality between SIAE and PS20 degradation. The lipase activity of SIAE is specific to PS20, but not to PS 80 (PS80), which contains monoesters with long chain fatty acid (C18) and higher-order esters. The specific esterase activity of SIAE on PS20 suggests a possible solution of using PS80 over PS20 to eliminate surfactant degradation in mAb products.

Identifiants

pubmed: 34487744
pii: S0022-3549(21)00470-6
doi: 10.1016/j.xphs.2021.09.001
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Polysorbates 0
Surface-Active Agents 0
Acetylesterase EC 3.1.1.6
sialate O-acetylesterase EC 3.1.1.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3866-3873

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sisi Zhang (S)

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.

Hui Xiao (H)

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States. Electronic address: hui.xiao@regeneron.com.

Ning Li (N)

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, United States.

Articles similaires

Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
Animals Rumen Methane Fermentation Cannabis
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Antigen targeting and anti-tumor activity of a novel anti-CD146

Kim Lindland, Marion Masitsa Malenge, Ruth Gong Li et al.
1.00
Animals Humans CD146 Antigen Mice Immunoconjugates

Classifications MeSH